Case Study
Science 37 Accelerates Timelines and Expands Reach in Infectious Disease Study.
Science 37
The Science 37 Metasite: The Power of 20 Sites in One.
Science 37
The Science 37 Metasite: The Power of 20 Sites in One.
Study enrollment rates have declined by more than 50% from pre-pandemic levels. To meet today’s challenges, the Science 37 Metasite expands your access to untapped patient populations and liberates you from geography and diversity limitations. With the Metasite, you’ll accelerate study recruitment and enrollment, while delivering high-quality data.
Study enrollment rates have declined by more than 50% from pre-pandemic levels. To meet today’s challenges, the Science 37 Metasite expands your access to untapped patient populations and liberates you from geography and diversity limitations. With the Metasite, you’ll accelerate study recruitment and enrollment, while delivering high-quality data.
SCIENCE 37
Study enrollment rates have declined by more than 50% from pre-pandemic levels. To meet today’s challenges, the Science 37 Metasite expands your access to untapped patient populations and liberates you from geography and diversity limitations. With the Metasite, you’ll accelerate study recruitment and enrollment, while delivering high-quality data.
Expanded Access to Patients Accelerates and Enhances your Clinical Trial.
There’s no substitute for speed. Compared to traditional site-based studies, the Science 37 Metasite accelerates your study’s recruitment and start up, while enabling greater patient retention and inclusivity.
Trials Without Science 37
Limited Participation: Only 8% of patients participate in traditional clinical research.
Slower Execution: Average start-up time is 31.4 weeks, with 80% delayed from enrollment.
Poor Retention: On average, trials have a 70% retention rate.
Limited Diversity: Only an average of 14% non-white representation.
Trials With the
Science 37 Metasite
Access to the remaining 90%+ of the patient population.
More than 2x faster trial startup—
entire countries launched in a single day.
96%+ patient retention.
3x greater diversity.
Making Clinical Trials Faster, More Inclusive, and Patient-Centric.
Access Patients Beyond Site Geography
Enable Faster Trials with Omnichannel Recruitment
Collect High-Quality Data from Anywhere
Deliver Flexible Treatment - Both At-Site and Remote
Why Choose a Metasite?
A Metasite exists alongside traditional sites, improving patient experience- enabling faster trials.
Faster
Patient Recruitment.
Use a data-driven, omnichannel approach that makes it easier to recruit and enroll patients.
Accelerated Start-Up Times.
Meet clinical trial deadlines without sacrificing quality.
Better
Patient Experience.
The platform, people and processes designed to retain patients longer.
More Diversity.
Generate a more real-world representation with robust recruitment and expansive networks.
Recruitment Engine: Centralized Patient Engagement Ensures 100% Follow Up. - Cloned
The Science 37 Metasite leverages real-world prevalence data to deliver data-driven feasibility assessments and uses an omni-channel recruitment approach to select the best channel for reaching receptive patients. Interactive screeners and a Centralized Patient Engagement Center drive high-efficiency enrollment so that no patient is lost to follow up.
Recruitment Engine: Centralized Patient Engagement Ensures 100% Follow Up. - Cloned
The Science 37 Metasite leverages real-world prevalence data to deliver data-driven feasibility assessments and uses an omni-channel recruitment approach to select the best channel for reaching receptive patients. Interactive screeners and a Centralized Patient Engagement Center drive high-efficiency enrollment so that no patient is lost to follow up.
Clear, Consistent Experiences Drive Compliance and Data Quality.
In the skilled hands of the Science 37 team, every step of the patient journey is a high-touch experience that drives study conduct excellence. The Metasite’s easy-to-follow and standardized processes deliver greater consistency, compliance, and data accuracy—ensuring reliability for regulators according to GCP standards.
The Patient Experience
From enrollment through study completion, the patient follows intuitive, app-based processes using their everyday mobile device. Embedded videos and user prompts guide them. The patient’s entire journey is supported by a unified platform and the Science 37 team.
The Investigator Experience
A digital schedule of assessments gives total visibility into where each patient is in their individual journey. The Metasite eliminates ambiguity and ensures consistency and compliance across every participant.
The Visit Experience
The telemedicine investigator, mobile nurse and patient triangulate care from the comfort of the patient’s home. All visit information has been remotely coordinated and is laid out for use by the investigator right at their fingertips.
The Mobile Nurse Experience
All data is captured directly into the system from all stakeholders, including the mobile nurse, who can record procedure results as they are performed in a centralized, standardized way.
Eliminate the Need for Data Re-Entry.
The moment a study facilitator enters data and hits “submit”, the data is captured in the system and reflected in the patient journey without the need for manual re-entry.
Eliminate the Need for Data Re-Entry.
The moment a study facilitator enters data and hits “submit”, the data is captured in the system and reflected in the patient journey without the need for manual re-entry.
Proof the Science 37 Metasite™
Is Working on Every Level.
Sponsors and CROs who partner with Science 37 get access to the full range of Metasite capabilities at scale.
150+
Trials Launched
3x
More Diversity than Traditional Sites
33M+
Patients Accesible
34k+
Physician Providers
(contracted for research)
The Science 37 Metasite in Action.
Sponsors and CROs are Using Science 37 to Expand Access to Clinical Trials Globally.
“[The Science 37] Metasite™ strategy complements the conventional site mix to accelerate the recruitment of patients in remote locations and in underrepresented communities.”
IDC Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment, #US50382823, March 2023
“Science 37 places a significant emphasis on training. Healthcare staff are trained on the platform used in clinical trials, ensuring that when the patient and provider come into contact during any DCT, the patient experience is easy, and the data collected is accurate.”
GlobalData
“Science 37 delivers a model that truly supports patient preference—providing access through the site or through a DCT model. The patient’s choice is front and center.”
Clinical Trial Sponsor
“Science 37 allows us to enroll patients who don’t traditionally participate in trials, decreasing burden on patients and site, improving diversity and reach.”
Clinical Trial Sponsor
